Results 201 to 210 of about 2,665,426 (306)

Deposition pattern and amino acid sequence analysis of amyloid-β in Felidae species. [PDF]

open access: yesJ Vet Med Sci
Fukui H   +5 more
europepmc   +1 more source

The complete chloroplast genome sequence of the medicinal plant Stephania brachyandra Diels 1910 (Menispermaceae, Ranunculales) and phylogenetic analysis

open access: diamond
Van Tu Duong   +6 more
openalex   +1 more source

Therapeutic strategies for MMAE‐resistant bladder cancer through DPP4 inhibition

open access: yesMolecular Oncology, EarlyView.
We established monomethyl auristatin E (MMAE)‐resistant bladder cancer (BC) cell lines by exposure to progressively increasing concentrations of MMAE in vitro. RNA sequencing showed DPP4 expression was increased in MMAE‐resistant BC cells. Both si‐DPP4 and the DPP4 inhibitor sitagliptin suppressed the viability of MMAE‐resistant BC cells.
Gang Li   +10 more
wiley   +1 more source

A comprehensive machine learning for high throughput Tuberculosis sequence analysis, functional annotation, and visualization. [PDF]

open access: yesSci Rep
Hossain MS   +10 more
europepmc   +1 more source

Infrared laser sampling of low volumes combined with shotgun lipidomics reveals lipid markers in palatine tonsil carcinoma

open access: yesMolecular Oncology, EarlyView.
Nanosecond infrared laser (NIRL) low‐volume sampling combined with shotgun lipidomics uncovers distinct lipidome alterations in oropharyngeal squamous cell carcinoma (OPSCC) of the palatine tonsil. Several lipid species consistently differentiate tumor from healthy tissue, highlighting their potential as diagnostic markers.
Leonard Kerkhoff   +11 more
wiley   +1 more source

Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapies

open access: yesMolecular Oncology, EarlyView.
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala   +15 more
wiley   +1 more source

Sequencing and sequence analysis v1 [PDF]

open access: yes, 2019
Norfitriah Mohamed Sohaimi   +4 more
openaire   +1 more source

Genetic modifiers of response to thalidomide in transfusion-dependent beta-thalassemia patients: a whole-exome sequence analysis. [PDF]

open access: yesPeerJ
Bawazir WM   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy